Durgical
EN
Open the app

Anticoagulants and antiplatelets around procedures

  • Treatment and support

Stopping a blood thinner for surgery risks a stroke or clot; continuing it risks bleeding. The skill is weighing the two for each patient and procedure.

Updated

What it is

Perioperative management of antithrombotic drugs balances two risks: bleeding from the procedure and clotting while the drug is off. Many minor procedures can be done without interruption. When a drug must be stopped, how long before depends on how fast it wears off and on kidney function. Bridging means covering the gap left by warfarin with a short-acting heparin; it is reserved for patients at the highest risk of clotting, because it adds bleeding. Direct oral anticoagulants wear off quickly and are not bridged. Antiplatelets after a recent coronary stent are a special case decided with the cardiologist.

What to know

  • Low-bleeding-risk procedures (most dental extractions, cataract, skin surgery, diagnostic endoscopy) are often done without stopping the anticoagulant, using local haemostasis.
  • Warfarin takes several days to wear off; the INR is checked before surgery, and vitamin K can correct a still-high value.
  • Bridging with heparin is for the highest thrombotic risk: mechanical mitral or older-design valves, a stroke or venous clot in recent months, or a severe thrombophilia.
  • In atrial fibrillation, routine bridging of warfarin increased bleeding without reducing stroke in a randomised trial, so most patients are not bridged.
  • Direct oral anticoagulants are stopped for a period set by the drug, the kidney function (dabigatran depends most on the kidneys) and the bleeding risk; they are not bridged.
  • Aspirin is usually continued, except in closed-space surgery such as neurosurgery or some spinal, eye and urological operations.
  • After a coronary stent, stopping dual antiplatelet therapy early can cause stent thrombosis; elective surgery is postponed until the minimum course is complete.

How it is done (and why)

  1. Ask: what drug, why it was started, when the last dose was, and how well the kidneys work.
  2. Grade the procedure's bleeding risk; if low, plan to continue the drug with local haemostasis.
  3. Grade the patient's clotting risk while off the drug (valve type, recent clot or stroke, thrombophilia, cancer).
  4. If the drug must stop: time the last dose by its half-life and kidney function, using the local protocol.
  5. Bridge only warfarin and only in the highest clotting risk; DOACs and antiplatelets are not bridged.
  6. Neuraxial anaesthesia has its own stop and restart intervals (see the anaesthesia page).
  7. Restart once haemostasis is secure: DOACs act within hours, so restart later after high-bleeding-risk surgery; give clot prophylaxis meanwhile.

How each drug class is handled around a procedure

Drug classHow it wears offBridging?Check beforeRestart
WarfarinSlowly, over days, as factors are remadeOnly in the highest clotting riskINR; vitamin K if still highWhen bleeding is controlled; heparin cover until the INR is in range if bridged
DOACs (apixaban, rivaroxaban, edoxaban, dabigatran)Quickly, within days; longer with poor kidney functionNoKidney function; drug level only if urgentFull effect within hours: delay after high-bleeding-risk surgery
Low-molecular-weight heparinWithin about a day; cleared by the kidneysIt is the usual bridgeKidney function, plateletsProphylactic level first, full level once haemostasis is secure
AspirinPlatelets stay blocked for their lifespanNoWhy it is taken (stent, stroke, primary prevention)Usually continued (always with a stent or for secondary prevention); may be stopped for primary prevention or closed-space surgery; restart early if stopped
P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel)Several days, as new platelets are madeNo (specialist plans only)Date and type of stent; cardiology opinionAs soon as bleeding allows, especially after a stent

Risks and precautions

  • The commonest harm is not bleeding but an unnecessary stop: a patient told to stop an anticoagulant for a minor procedure who then has a stroke.
  • A patient with a drug-eluting coronary stent placed recently who needs urgent surgery keeps aspirin and is discussed with cardiology before the P2Y12 inhibitor is stopped.
  • Emergency surgery on an anticoagulant is a reversal problem, not a bridging one: see the page on bleeding on anticoagulants.
  • Write the plan down with dates: last dose, any bridge, restart, and who to call; most errors happen at handovers.

Monitoring and next step

  • Kidney function before every DOAC or heparin plan, because it changes how long the drug lasts.
  • INR before surgery on warfarin; correct a high value with vitamin K if time allows.
  • Platelet count before and during heparin bridging, watching for heparin-induced thrombocytopenia.
  • Urgent surgery on a DOAC: a drug-specific level (calibrated anti-Xa or dilute thrombin time), as the laboratory offers.
  • After surgery: haemoglobin and wound checks before the full anticoagulant level is resumed.

Common traps

  • Bridging every patient who stops warfarin: in most atrial fibrillation it adds bleeding without preventing strokes
  • Bridging a DOAC with heparin: DOACs wear off and come back quickly, so a bridge only adds overlap and bleeding
  • Stopping all antiplatelets after a recent coronary stent for elective surgery: stent thrombosis is often fatal, so the surgery is postponed or cardiology decides
  • Using one fixed stop time for dabigatran in every patient: it is cleared by the kidneys, so poor renal function needs a longer stop
  • Restarting a full anticoagulant level the evening after major surgery: full effect arrives within hours and can turn a dry wound into a haematoma

Test yourself

Think of the answer, then tap the question to see it.

A 72-year-old on apixaban for atrial fibrillation needs a hip replacement. Should he be bridged with heparin, and why?

No: apixaban wears off and acts again within hours, so it is simply stopped for a period set by kidney function and bleeding risk, then restarted once haemostasis is secure.

A woman with a mechanical mitral valve on warfarin needs a colectomy. Which plan fits best?

Stop warfarin and bridge with heparin: a mechanical mitral valve is among the highest clotting risks, so the gap without anticoagulation must be covered.

A man had a drug-eluting coronary stent placed two months ago and is booked for an elective hernia repair. What next?

Postpone the elective surgery and discuss with cardiology: stopping dual antiplatelet therapy this early risks stent thrombosis.

Why does dabigatran need a longer stop before surgery than apixaban in a patient with poor kidney function?

Dabigatran is cleared mostly by the kidneys, so its effect lasts much longer when they work poorly; apixaban depends less on them.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: Update in Perioperative Ischemic Workup: Integrating 2024 AHA/ACC Guidelines and Contemporary Evidence (Journal of Cardiovascular Development and Disease (Europe PMC open access), 2026); Perioperative Anticoagulation Management (StatPearls (NCBI Bookshelf), 2023); Antiplatelet Medications (StatPearls (NCBI Bookshelf), 2022).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.